Publications by authors named "Edward Newman"

Claim this Profile
A
A phase 1 study of orally administered 5-fluoro-2'-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors.
Alice P Chen, Shivaani Kummar, Larry Rubinstein, Jennifer Zlott, Geraldine O'Sullivan Coyne, Edward M Newman

Cancer Chemother Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).
Mamta Parikh, Nataliya V Uboha, Naoko Takebe, Kit Tam, Philippe L Bedard, Edward M Newman

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative Analysis.
Joseph M Tuscano, Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Edward M Newman

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in depression, anxiety, and quality of life in Parkinson's disease before and after deep brain stimulation surgery: a multicentre cohort study.
Molly G Abbott, Arteen Ahmed, Nicola Pavese, Antonella Macerollo, Edward J Newman

BMJ Neurol Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Interventions for Sialorrhoea in People with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Fariha Naeem, James Reid, Matthew Bailey, Amanda Reid, Clare Smyth, Edward J Newman

Mov Disord Clin Pract· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Carolyn E Behrendt, Miguel A Villalona-Calero, Edward M Newman, Paul H Frankel

Contemp Clin Trials· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
Jonathan W Riess, Karen L Reckamp, Paul Frankel, Jeffrey Longmate, Karen A Kelly, Edward M Newman

Clin Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
Sumanta K Pal, Paul H Frankel, Amir Mortazavi, Matthew Milowsky, Ulka Vaishampayan, Edward Newman

JAMA Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.
David I Quinn, Denice D Tsao-Wei, Przemyslaw Twardowski, Ana M Aparicio, Paul Frankel, Edward Newman

Invest New Drugs· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Jacob S Thomas, Anthony B El-Khoueiry, Barry J Maurer, Susan Groshen, Jacek K Pinski, Edward M Newman

Cancer Chemother Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Stephen Keddie, Julia Pakpoor, Christina Mousele, Menelaos Pipis, Pedro M Machado, Edward J Newman

Brain· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design.
Jonathan W Riess, Paul Frankel, David Shackelford, Mark Dunphy, Ramsey D Badawi, Edward Newman

Clin Lung Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology.
Paul H Frankel, Vincent Chung, Yan Xing, Jeff Longmate, Susan Groshen, Edward M Newman

Curr Probl Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
by Melanie Reid.
Nicholas Scott, Danielle J Leighton, Edward J Newman

Pract Neurol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency presentations of movement disorders.
Sacha E Gandhi, Edward J Newman, Vicky L Marshall

Pract Neurol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors.
Geraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M Covey, Edward M Newman

Cancer Chemother Pharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies.
Paul H Frankel, Vincent Chung, Joseph Tuscano, Tanya Siddiqi, Sagus Sampath, Edward M Newman

JAMA Netw Open· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma.
Robert Chen, Alex F Herrera, Jessie Hou, Lu Chen, Jun Wu, Edward M Newman

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies.
Tanya Siddiqi, Paul Frankel, Jan H Beumer, Brian F Kiesel, Susan Christner, Edward M Newman

Leuk Lymphoma· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma.
Joseph M Tuscano, Emanual Maverakis, Susan Groshen, Denice Tsao-Wei, Guillaume Luxardi, Edward M Newman

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.
Thehang Luu, Paul Frankel, Jan H Beumer, Dean Lim, Mihaela Cristea, Edward M Newman

Cancer Chemother Pharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurological Scottish neologisms.
John Paul Leach, Krishna Dani, Niall J MacDougall, Paul Gallagher, Edward J Newman

Pract Neurol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653).
Sarmad Sadeghi, Susan G Groshen, Denice D Tsao-Wei, Rahul Parikh, Amir Mortazavi, Edward Newman

J Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syncope in a new mother: a case of long-QT syndrome presenting after childbirth.
Ryan Wereski, Richard Dobson, Edward J Newman, Derek Connelly

J R Coll Physicians Edinb· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ()-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303).
Karen L Reckamp, Paul H Frankel, Nora Ruel, Philip C Mack, Barbara J Gitlitz, Edward M Newman

Front Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis